Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001348362-25-000003

Options or other derivatives

  • Director acquired 11,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
McKechnie William Edward Director 2025-05-15 Grant or award · Stock Options +11,000 63,000 D: show line 1 in the form
Loading xslF345X05/primary_doc.xml…